Equashield 1

Equashield

Provider of hazardous drug compounding technologies globally

Equashield is a leading global provider of closed system transfer devices (CSTDs) designed to protect healthcare professionals from exposure to hazardous drugs. With a relentless focus on quality, safety, and ease of use, Equashield’s product offerings are based on proprietary technologies spanning both manual CSTDs and novel automated compounding solutions – including a next-generation automated compounding system utilising artificial intelligence to deliver superior performance.

Company Background

Since its founding in 2009, Equashield has recorded robust growth fuelled by continued product innovation, high customer satisfaction, and the pioneering of new technological solutions for handling hazardous drugs

Products are sold across five continents Equashield is a leading CSTD provider in the largest global market, the United States

Vision & Outlook

Opportunity to leverage Equashield’s technological edge to further accelerate growth

Pipeline of innovative compounding technologies, including a novel automated drug compounding system

Vast potential of compounding automation to improve safety and efficiency in the handling of hazardous drugs

EQ Logo CMYK 2021 2

SECTOR

Healthcare

EMPLOYEES

>450

OWNERSHIP

Fund XI

INVESTMENT DATE

2022

HEAD OFFICE

Tefen, Israel

MANAGEMENT

Eric Shem-Tov

CEO

Itamar Petersil

CFO

RESPONSIBLE ADVISOR

Joel Davidkin

Managing Director